Top Story

Nanobiotix initiates trial of drug for liver metastasis and HCC

July 3, 2015

The French National Agency for Medicines and Health Products has given Nanobiotix authorization to begin a clinical trial investigating its drug NBTXR3 for the treatment of liver metastasis and hepatocellular carcinoma, according to a press release.

The trial, which is a part of the nanomedicine Nano Innovation for CancEr consortium, will be multinational, nonrandomized, phase 1/2 studies evaluating the use of NBTXR3 with high doses of stereotatic body radiation therapy (SBRT), according to the release.

In the Journals

Physician urges FDA not to lift restrictions on drug makers’ claims about their products

July 3, 2015
Drug regulations and a governing body to mandate them is a necessity for patients’ safety and health care providers’ peace-of-mind, according to a recently…
In the Journals

Radiofrequency ablation safe, effective for medically inoperable NSCLC

July 2, 2015
Radiofrequency ablation conferred 2-year OS rates comparable to stereotactic body radiotherapy in patients with medically inoperable non–small cell lung cancer…
Meeting News Coverage

Clinical trials, health information technology platform to test power of precision medicine

July 2, 2015
CHICAGO — Precision medicine represents a potentially practice-changing advance in the landscape of cancer treatment. Yet, the ability to gather and analyze data…
Drug Pipeline

New collaboration looks to bring potential liver cancer, melanoma drug to China

July 2, 2015
Provectus Biopharmaceuticals, Inc. announced it has signed a Letter of Intent with Boehringer Ingelheim Investment Co. Ltd. in China to collaborate in marketing its…
More News Headlines »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
morganatic-roan
morganatic-roan